Moreover, in the different genotyping of CD39, the expression in the wild subtype (original gene) was higher than the mutant subtype (gene mutation), and the CD39 expression in primary gliomas were higher than recurrent gliomas (Figure 1A). The gene discussed is ENTPD1; the disease is central nervous system cancer.